|
Recent Developments |
|
16-JUL-13
Jenburkt Pharmaceuticals announced on Monday that the board has appointed Ashish U. Bhuta as chairman and managing director with effect from July 16, 2013 to Mar. 31, 2016. He was serving as the whole time director.
Future Plans
Jenburkt has an ambitious plan with regard to exports, especially to African countries. The company is developing new formulations as per the requirements of the importing counties. Also, product registrat... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 30-Sep-2015(6) | 31-Mar-2015(12) | 31-Mar-2014 (12) | | Net sales | 469.69 | 850.18 | 762.00 | | Other Income | 11.84 | 20.72 | 16.12 | | Total Income | 481.53 | 870.90 | 778.12 | | Cost of goods sold | 385.38 | 699.57 | 647.10 | | OPBDIT | 96.15 | 171.33 | 131.02 | | PAT | 59.83 | 99.89 | 75.06 | | Gross Block | - | - | - | | Equity capital | 46.49 | 46.49 | 46.49 | | EPS (Rs.) | - | - | 16.51 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | - | 3.88 - 6.29 | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 20.0 | 19.7 | 16.8 | | Net margin (% of OI) | 12.4 | 11.5 | 9.6 |
|
|
Detailed Financials
|
|
|
|
|
